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L.arginine depletion inhibits glomerular nitric oxide synthesis and
exacerbates rat nephrotoxic nephritis. Nitric oxide (NO) synthesis is
induced in glomeruli in glomerulonephritis; its role in the pathogenesis of
glomerular injury is unknown. Interpretation of its role using the currently
available analogues of L-arginine as in vivo inhibitors of NO is compli-
cated by their lack of specificity for inducible NO synthase (iNOS). As NO
synthesis by iNOS depends on extracellular L-arginine, we have here
examined effects of L-arginine depletion on glomerular NO synthesis and
the course of accelerated nephrotoxic nephritis (NTN). Arginase, which
converts L-arginine to urea and L-ornithine, was used to achieve L-
arginine depletion. A single dose of iv. arginase produced complete
depletion of plasma arginine for four hours. Two forms of NTN were
induced in preimmunised rats by nephrotoxic globulin: (1) the systemic
form of the model by intravenous nephrotoxic globulin; or (2) the
unilateral form of model by left kidney perfusion with nephrotoxic
globulin, which avoids the complications of systemic administration of
nephrotoxic globulin. Arginase reduced plasma arginine levels and the
synthesis of nitrite (the stable end-product of NO) by NTN glomeruli(95% inhibition). Proteinuria was exacerbated. There was no effect on
early (24 hr) leukocyte infiltration. In the systemic form of the model
arginine depletion by iv. arginase increased glomerular thrombosis at 24
hours, and the severity of histological changes at four days, accompanied
by systemic hypertension. In the unilateral form of the model, where iv.
arginase did not induce hypertension, there was no increase in thrombosis
or histological severity of nephritis. These results show that arginine
depletion, which inhibits glomerular NO synthesis in NTN, leads to
increased proteinuria. Where injury is severe, or accompanied by systemic
hypertension, the disease is further exacerbated by glomerular thrombosis.
These results suggest that NO has an important role in limiting acute
glomerular injury.
Nitric oxide (NO) synthesis is induced in glomeruli in acute
models of glomerulonephritis [1]. The source of the inducible NO
synthase (iNOS) activity is predominantly infiltrating macro-
phages [2], although in vitro evidence shows that intrinsic glomer-
ular cells are also potential sources [3, 4]. The role of NO in these
diseases has not yet been determined, one major obstacle to
progress being the current inability to selectively inhibit glomer-
ular iNOS while preserving basal vascular tone, as glomerular
injury is exacerbated by systemic hypertension [5].
Synthesis of NO by iNOS is critically dependant on extracellular
arginine levels. In activated macrophages NO synthesis is im-
paired when cells are cultured in arginine-free medium despite
high intracellular arginine concentrations and minor recycling of
citrulline to arginine via arginosuccinate synthetase [6], This
dependence on extracellular arginine suggests arginine depletion
as an in vivo strategy for inhibiting iNOS dependant NO synthesis.
Arginase, which converts L-arginine to urea and ornithine and
therefore shares a common substrate with NOS, has been shown
to deplete plasma L-arginine levels in vivo to levels that do not
affect basal blood pressure [7], and in early studies on tumor
inhibition was shown to have no significant toxicity. In a recent
study we have shown that L-arginine depletion by arginase
reduces NO synthesis as detected by electron paramagnetic
resonance spectroscopy in a model of endotoxic shock [8].
We therefore studied the effects of bovine liver arginase
administration on plasma arginine levels, glomerular NO synthe-
sis and the course of experimental glomerulonephritis. We chose
the model of accelerated nephrotoxic nephritis (NTN) as this
injury is macrophage-dependant [9] and we have previously
demonstrated the time course of NO synthesis and induction of
iNOS in this model [1, 10]. We studied the standard form of the
model, and developed a unilateral form of the disease by renal
perfusion with nephrotoxic globulin that enabled us to study the
consequences of L-arginine depletion without systemic effects of
nephrotoxic globulin or systemic hypertension. We studied these
models at six hours and 24 hours and at four days. Six hours was
chosen since at this time there was maximal arginine depletion.
Twenty-four hours was the time at which we previously found
maximal nitrite generation by glomeruli in this model [1]. We
studied the models at four days to see whether the early peak of
NO synthesis was critical for the progression of the disease.
Methods
Animals
Inbred male Lewis rats (200 to 280 g) from St. Mary's Hospital
Medical School fed on standard rat chow were used.
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Isolation of peritoneal macrophages
Peritoneal macrophages were obtained by peritoneal lavage
with calcium free perfusion buffer (pH 7.4) from rats injected 10
days previously with 0.2 ml Corynebacterium parvum (7 mg/mI;
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Weilcome). Macrophages were plated at 106/ml in 16 mm wells
and were washed three times after two hours to remove non-
adherent cells.
Glomerular isolation
Glomeruli were isolated by differential sieving of saline per-
fused nephritic kidneys from systemic NTN rats seven hours or
one day after i.v. nephrotoxic globulin as previously described
[11]. Glomeruli were washed twice in culture medium and incu-
bated in 16 mm plastic wells at 2000/mi in tissue culture wells
(Nunc, Uxbridge, UK).
Glomerular and macrophage nitrite (N02) assay
Glomeruli or macrophages were incubated for 48 hours at 37°C
under 4% CO2. Culture medium was DMEM without phenol red
supplemented with 0.1% bovine serum albumin (Sigma); glu-
tamine (4 mM; Sigma); and penicillin 100 U/ml, streptomycin 100
.g/m1 and amphotericin B 250 ng/ml (Sigma). The concentration
of L-arginine in this medium is 0.4 mM.
Medium in some wells was supplemented with 1 jsg/ml LPS (E.
coli 0127:B8, Sigma); or with 300 LM NGmonomethylLarginine
(L-NMMA, gift of Dr. S. Moncada, Welicome Research Labora-
tories, Beckenham, Kent, UK). Macrophages were cultured in
presence or absence of increasing doses of bovine liver arginase
(Sigma). Glomeruli were cultured with or without 10 U/mI
arginase.
Nitrite in culture supernatants was measured by the Griess
reaction as previously described [1]. Sodium nitrite was used as
standard, and values were derived by subtracting background
N02 present in the control medium incubated without cells or
glomeruli for 48 hours.
Viability of isolated macrophages cultured in the presence of
arginase for 48 hours was determined as previously described [12],
using fluorescein diacetate (FDA, Sigma) and ethidium bromide
(Sigma).
Glomerulonephritis
Induction of accelerated nephrotoxic nephritis (NTN). Two
variants of this model were used: a systemic form [9] and a
unilateral form. Systemic NTN was induced by immunisation of
rats with I mg rabbit immunoglobulin (Sigma) in Freund's
complete adjuvant (Sigma) i.p. one week prior to an i.v. subne-
phritogenic dose (6 mg/I 00 g body wt) of rabbit anti-rat nephro-
toxic globulin. Pre-immunized controls received normal rabbit
globulin instead of nephrotoxic globulin. A unilateral form of
NTN was induced by perfusion of the left kidney with nephrotoxic
globulin followed by right nephrectomy; these rats were pre-
immunized subcutaneously rather than intraperitoneally. The
technique of this perfusion was as previously described [13]. Nine
milligrams of nephrotoxic globulin were delivered as a 0.5 ml
volume and flushed out with saline after three minutes. Controls
received saline instead of nephrotoxic globulin. The total ischemia
time was less than ten minutes.
Rats were transferred to metabolic cages (Modular Systems &
Development Company Ltd, Hereford) one hour after nephro-
toxic globulin for six or twenty-four hour periods of urine collec-
tion. The level of urinary protein was measured by the method of
suiphosalicylic acid precipitation. Results are expressed as milli-
grams of protein excreted per 24 hours.
For plasma amino acid analysis 0.7 ml of blood was taken by tail
bleed into heparin (100 U/m1 1, CP Pharmaceuticals Ltd.) After
centrifugation the plasma was removed and analyzed by HPLC for
arginine, ornithine and citrulline concentrations as described
previously [14]. Plasma creatinine was measured by the Jaffe
reaction on an automatic analyzer.
Systolic blood pressure was measured in conscious rats using a
tail cuff transducer (Harvard Instruments). A constant ambient
temperature of 30°C was maintained. A training period of four
days to accustom the rats to the technique preceded the start of
the experiment.
For histological and immunohistochemical studies tissue was
fixed in neutral buffered formal saline and embedded in paraffin
wax. Sections were stained with hematoxylin/eosin and periodic
acid-Schiff reagent and coded before histological assessment.
Twenty glomeruli per kidney were counted. Thrombi were scored
as 0 to 4 depending upon the mean number of glomerular
quadrants affected. The glomeruli were also examined for hyper-
cellularity and scored for neutrophil and macrophage infiltration.
Macrophages were quantitated by immunohistochemical staining
on formalin fixed tissues using monoclonal anti-rat macrophage
antibody ED1 (Serotec, Kidlington, UK) [15] with a peroxidase
labeled secondary antibody (Dako, High Wycombe, UK.) Results
of thrombus scores and cell counts were divided by twenty and
expressed per glomerulus.
Experiments studying the effects of arginase treatment
on glomerulonephritis
The effect of a single dose of bovine liver arginase on normal rat
plasma amino acids and creatinine levels was determined. Normal
rats were given a single i.v. dose of 2500 units of arginase dissolved
in 1 ml of saline. Blood was taken immediately before the
injection, after one, four, and eight hours and at sacrifice at 24
hours. Blood pressure was measured three hours after arginase.
Urine was collected over 24 hours and samples of kidney, liver,
spleen and lung taken at sacrifice for histology. Effect of arginase
treatment was then studied in the systemic and unilateral models
of NTN.
Systemic NTN. Arginase or saline treatment was given as two
doses, an initial i.v. 2500 units one hour before nephrotoxic
globulin or normal rabbit globulin, and a second i.v, dose of 1250
units eight hours later. Blood and a renal biopsy were taken on
day I and nephrectomy at sacrifice on day 4. Urine was collected
over the first six hours, at 24 hours and day 4. To determine effects
on blood pressure and on glomerular nitrite generation, separate
rats were given the first dose of arginase or saline only, and blood
pressure measured three hours later or glomeruli extracted at
sacrifice at eight hours.
Unilateral NTN. Arginase or saline treatment was given as 2
doses, an initial i.v. 2500 units one hour before renal perfusion
with nephrotoxic globulin or saline, and a second i.v. dose of 1250
units eight hours later. Blood, renal tissue and urine were
examined as in the systemic form of the model. To determine the
effects on blood pressure separate rats were given the first dose of
arginase or saline, unilateral NTN was induced and then blood
pressure was measured three hours later.
Statistics
Data are expressed as mean SEM. For statistical comparisons,
Student's one-tailed t-test was used. Levels of significance are
quoted at P < 0.05 and P < 0.01.
1092 Waddington et al: L-arginine depletion in nephrotoxic nephrztis
Table 1. Effect of in vitro arginase on nitrite production by
nephritic glomeruli
Nitrite concentration .rM
+Arginase +LNMMA Control
Unstimulated 2.3 0.5 0.9 0.4" 4.3 1.2
LPS stimulated 4.8 L3' 1.9 0•7h 40.0 6.5
Results
Effect of arginase on viability and N02 synthesis of macrophages
Viability and N02 synthesis of C. parvum macrophages after
48 hours in culture with increasing doses of arginase is shown in
Figure 1. Incubation with 5 or 10 U/mI arginase induced a
significant reduction in NO2 - synthesis as compared to macro-
phages cultured without arginase (5 U arginase 11.8 0.6 .tM; N
= 3; 10 U arginase 2.2 0.9; N = 3; no arginase 46.3 2.2; N =
3; P < 0.01 at both doses). There was no significant decrease in
viability at these doses.
Effect of in vitro arginase on NO2 production by
nephritic glomeruli
The effect of incubation with 10 U/ml arginase on N02
production by glomeruli 24 hours after induction of NTN is shown
in Table 1. This concentration was used as it significantly reduced
in vitro macrophage NO2 without affecting viability. Glomerular
N02 production was significantly reduced in the presence of
arginase, both basally (P < 0.05) and when stimulated with LPS (P
<0.01). L-NMMA significantly reduced N02 production in both
basal (P < 0.05) and LPS-stimulated (P < 0.01) cultures.
Effect of arginase on glomerulonephritis
Survival. Survival in NTN without arginase treatment was 95%
in the systemic model, and 100% in the unilateral model. In
Table 2. Effect of in vitro arginase on nitrite production by
nephritic glomeruli
Culture conditions
Nitrite cone
Arginase
entration fLM
Saline
Unstimulated 2.7 0.4 3.4 0.6
+LNMMA 0.8±0.1 1.2±0.1
+LPS 13.0 1.6" 36.6 4.9
+LNMMA & LPS 1.4 0.0 2.9 0.6
Data are means SEM. Nephritic glomeruli (2000/mi) extracted from
systemic NTN rats seven hours after nephrotoxic globulin and incubated
for 48 hours with or without LPS (1 g/ml) or LNMMA (300 j.M).
Arginase treated NTN rats received 2500 units arginase i.v. an hour before
nephrotoxic globulin; controls received i.v. saline.
P < 0.01 vs. saline (N = 4 vs. 7, respectively)
arginase-treated rats survival was reduced to 62% in systemic
NTN but was 100% in unilateral NTN. The majority of the
arginase-treated rats which did not survive the experimental
period died within the first eight hours after arginase administra-
tion, with hemorrhages and generalized vasoconstriction.
The effect of arginase on plasma amino acid levels in normal
rats is shown in Figure 2. The amino acid levels in normal rats
were: arginine, 225 18 /.Lrvi; ornithine, 58 5 ivi; N = 12.
Arginase administration in normal rats reduced the mean plasma
arginine concentration to zero at one and four hours and to 45
12 !.tM at eight hours and caused a concomitant increase in the
ornithine concentration. Twenty-four hours later the arginine
concentration had almost returned to normal (200 20 .rM, N =
2); ornithine levels were still above the normal value (127 2 /LM)
at this time. Arginase had no significant effect on plasma creati-
nine levels at four and eight hours after a single dose of 2500 U
compared with saline controls [pre-arginase 31.5 1.7 j.mol/liter
(N = 6); post-arginase 4 hours 27.7 0.3 j.rmol/liter, 8 hours 29.3
1.9 jrmol/liter (N = 3); saline control 4 hours 30.7 1.8
i.rmol/liter, 8 hours 26.7 0.7 .rmol/liter (N = 3)]. Blood pressure
was not significantly different from normal (122 9 mm Hg, N =
4). No proteinuria, or pathological changes in kidneys, liver,
spleen or lungs, were observed.
Systemic NTN. In the first six hours, arginase-treated NTN rats
had significantly increased proteinuria compared to the saline-
treated group (44 11 mg/24 hr, N = 8; saline treated 5.5 2.5
mg/24 hr, N = 6; P < 0.01). Over the following sixteen hours
arginase treated rats had increased proteinuria (224 47 mg/24
hr; N = 7; saline treated 155 45 mg/24 hr; N = 8; P = 0.15), but
this did not reach statistical significance (Fig. 3).
The mean plasma arginine concentration at 24 hours was
significantly lower in arginase treated rats than in saline treated
rats (arginase treated 49 16 .rM, N = 7; saline treated 146 23
fLM, N = 8; P < 0.01). There was a significant increase in ornithine
levels in arginase treated compared to saline treated rats (arginase
treated 134 12 M, N = 7; saline treated 54 4 /.tM, N = 8; P
<0.01).
Nitrite production (Table 2) by glomeruli isolated from argi-
nase treated rats was reduced compared to the glomeruli from
saline treated rats. The attenuation was significant in LPS-
stimulated glomeruli (arginase treated 13.0 1.6, N = 7; saline
treated 36.6 4.9, N = 10; P < 0.01).
The results of the glomerular histology are shown in Table 3. At
24 hours there was increased glomerular thrombosis in arginase
100 50
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Fig. 1. Viability (E) and nitrite production •) by rat peritoneal macro-
phages incubated with arginase for 48 hours. Values are means SEM (N
6). P < 0.01 vs. no arginase.
0 1 5 10 50 100
Data are means SEM. Nephritic glomeruli (2000/mi) extracted from
rats 24 hours after nephrotoxic globulin were incubated for 48 hours with
or without LPS (1 rg/ml), arginase (10 U/mI) or LNMMA (300 j.M).
"P < 0.05, "p < 0.01 vs. control (N = 5)
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Fig. 2. Effect of 2500 units i.v aiginase on arginine (LI) and omithine (•)
levels in normal rats, pre-aiginase (N = 12), 1 and 8 hours (N = 5)and 4 and
24 hours (N = 2) post-arginase.
treated rats (thrombus score 1.87 0.43; N = 7; saline treated
0.91 0.27; N = 8; P < 0.05; Fig. 4), but no difference in
macrophage or neutrophil counts. At day four saline treated rats
showed moderate glomerular hypercellularity and a mild focal
mononuclear cell infiltrate in the interstitium. Arginase treated
rats showed more pronounced glomerular hypercellularity with
increased macrophage infiltration (16.6 2.6 macrophages/glo-
merulus; N = 6; saline treated 8.2 1.8; N = 6; P < 0.05) and
early crescents were found in a small number of glomeruli.
Arginase treated pre-immunized rats given normal rabbit glob-
ulin demonstrated no proteinuria or histological change in the
kidneys at either day 1 or day 4. Arginine levels at 24 hours were
significantly lower than in normal rats (135 4 N = 4;
normals 225 18 rrvi; N = 12; P < 0.01). This level was still
significantly higher than that found in arginase treated NTN rats
(49 16 /sM; N = 7; P < 0.05).
The blood pressure of arginase treated rats was increased (193
and 230mm Hg; saline treated 142 10 mm Hg; N 3; arginase
treated controls with normal rabbit globulin 109 7.5 mm Hg; N
= 4).
Unilateral NTN. Within the first six hours there was a significant
increase in urinary protein in the arginase-treated group com-
pared to the saline-treated group (arginase treated 6.4 1.7
mg/24 hr; N = 5; saline treated 2.4 1.1 mg/24 hr; N 4; P <
0.05). Over the following sixteen hours there was again a signifi-
cant increase in urinary protein in the arginase treated group (24.9
4.5 mg/24 hr; N = 9; saline treated 7.6 0.8 mg124 hr; N = 10;
P < 0.01; Fig. 5).
As in the systemic form of the model, arginase significantly
depleted the plasma arginine levels at 24 hours (36 11 .M; N =
9; saline treated 148 16 jstvi; N 10; P < 0.01) and increased
plasma ornithine (108 8 sM; saline treated 49 5 .rvi; P <
0.01).
The results of glomerular histology are shown in Table 4. There
was no difference between the arginase and saline treated groups
in day 1 glomerular thrombus scores, neutrophil counts or mac-
1—7 hours 8—24 hours 3—4days
Fig. 3. Effect of arginase on urina,y protein 1 to 7 hours, 8 to 24 hours and
3 to 4 days after induction of systemic NTN. Rats received i.v 2500 units
arginase (LI, N = 7) or saline (•, N = 8) one hour before i.v nephrotoxic
globulin and 1250 units arginase or saline eight hours later. *p < 0.01 vs.
saline control.
rophage counts. At day 4, in both groups, there was histological
evidence of glomerulonephritis with glomerular hypercellularity
(Fig. 6). In one severely affected rat there were, in addition,
occasional areas of segmental necrosis with neutrophil infiltration.
Ranking showed no difference between arginase or saline-treated
rats and there was no difference in macrophage counts. Arginase-
treated control rats preimmunized and perfused with saline rather
than nephrotoxic globulin showed no glomerular changes.
There was no significant difference in blood pressure between
the groups (arginase treated 115 8 mm Hg; N = 4; saline
treated 133 10 mm Hg; N 4; P = 0.09).
Discussion
We found that bovine liver arginase markedly inhibited NO
synthesis in rat peritoneal macrophages and inhibited NO synthe-
sis in nephritic glomeruli under basal and LPS-stimulated condi-
tions at a concentration which was not cytotoxic to macrophages
in culture. Furthermore, systemic arginase administration signifi-
cantly depleted plasma arginine in normal rats with the antici-
pated rise in ornithine levels. There was no change in blood
pressure or plasma creatinine indicating that this dose of arginase
has no effect on the activity of constitutive NOS in the normal
animal, and, while recognizing that plasma creatinine is not an
explicit measure of glomerular filtration rate, this suggests that
there is no effect on normal glomerular function. There was no
mortality and no tissue injury. We therefore proceeded to exam-
ine the effects of plasma arginine depletion on NTN.
We achieved significant plasma arginine depletion for the first
24 hours of NTN with two doses of arginase. NO synthesis was
inhibited in nephritic glomeruli isolated from these animals, and
this was accompanied by significant exacerbation of proteinuria in
the first 24 hours, the period of effective plasma arginine deple-
tion. At 24 hours there was no significant effect on either
neutrophil or macrophage infiltration. In the systemic form of the
model, where disease was induced by intravenous rabbit nephro-
toxic globulin, there was increased glomerular thrombosis at 24
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Table 3. Effect of arginase on glomerular histology in systemic NTN
24 Hours 4
Macrophages
Days
HypercellularityThrombi Neutrophils Macrophages
Arginase 1.87 0.43a 1.6 0.5 7.2 1.1 16.6 2.6a +++
Saline 0.91 0.27 0.6 0.2 7.8 1.0 8.2 1.8 ++
Arginase-treated NTN rats (N = 8); saline-treated NTN rats (N = 8). Thrombi are expressed as a mean number of thrombosed quadrants per
glomerulus. Neutrophils and macrophages are expressed as number per glomerulus. Hypercellularity is scored semiquantitatively ranging from 0 (no
hypercellularity) to + + + + (extremely hypercellular).P < 0.05
40
30
E
20
. 10
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1—7 hours 8—24 hours 3—4 days
Fig. 5. Effect of alginase on urina,y protein 1 to 7 hours, 8 to 24 hours and
3 to 4 days after induction of unilateral NTN. Rats received i.v 2500 units
arginase (LI) or saline (•) one hour before intrarenal nephrotoxic
globulin and 1250 units arginase or saline eight hours later * < 0.05
(arginase N = 5, controls N = 4) and < 0.01 (arginase N = 10,
controls N = 9).
Fig. 4. Glomendar thrombosis 24 hours after induction of systemic NTN. A.
With arginase. B. With saline (H+E stain, x280 magnification).
hours and increased histological severity at four days with an
increase in macrophage numbers. In the unilateral form of the
model, no such differences were found. At four days there were no
significant differences in proteinuria between arginase treated and
saline treated rats. The findings at four days are interesting, as
they show that NO inhibition at the earlier time point did not
affect subsequent proteinuria.
The increase in proteinuria we found in NTN has previously
been reported in nephrotoxic rats given L-arginine analogues that
are competitive inhibitors of NO [16], but interpretation of results
has been complicated by concomitant systemic hypertension. We
show here that this effect can occur in the absence of systemic
hypertension. As there was no effect on infiltrating neutrophils or
macrophages at the time of increased proteinuria (despite other
reports of increased leukocyte infiltration with NO inhibition
[17]), the mechanism of this enhanced early proteinuria appeared
to be leukocyte-independent. Micropuncture studies strongly sug-
gest that the vasodilator properties of NO have protective effects
on glomerular hemodynamics [18], counteracting increases in
glomerular pressure due to vasoconstrictors. As thromboxane and
lipoxygenase products are known to increase during the early
phase of nephrotoxic nephritis [19], resulting in increased glomer-
ular pressure and reducing Kf, local generation of NO in acute
glomerulonephritis may have a crucial protective role in antago-
nizing these effects. NO inhibition will therefore have a detrimen-
tal effect on acute glomerular hemodynamic injury with exacer-
bation of proteinuria. Another possible explanation for the
increase in proteinuria is that inhibition of NO allows unopposed
activity of superoxide. NO may scavenge superoxide, and in a
model of hepatic necrosis NO inhibition results in an increase in
*
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Table 4. Effect of arginase on glomerular histology in unilateral NTN
24 Hours 4 Days
— _________________
Thrombi Neutrophils Macrophages Macrophages Hypercellularity
Arginase 0.9 0.3 0.68 0.1 5.3 0.2 7.6 1.1 +
Saline 0.45 0.25 0.66 0.1 4.2 0.9 8.8 1.3 +
Arginase-treated NTN rats (N = 9), saline-treated NTN rats (N = 10). Thrombi are expressed as a mean number of thrombosed quadrants per
glomerulus. Neutrophils and macrophages arc expressed as number per glomerulus. Hypercellularity is scored semiquantitatively ranging from 0 (no
hyperccllularity) to + + + + (extremely hypercellular).
of hypertension or possibly the increased level of injury in this
form of the model compared with the unilateral form. Enhanced
glomerular thrombosis has been reported with NO inhibition in
endotoxin treated rats [23], experiments that were also compli-
cated by the development of significant hypertension. In our
experiments, this was only present in the arginase treated rats with
the systemic form of NTN and not when arginase was given to
normal rats, control pre-immunized rats or in the unilateral form
of NTN where no systemic nephrotoxic globulin was given. A
previous report using arginase infusion [7] also showed no effects
on resting blood pressure, suggesting that plasma arginine levels
have little or no effect on basal NO synthesis by constitutive NOS.
In contrast, agonist-stimulated NO synthesis was blunted by
plasma arginine depletion, supporting arginine dependence of
increased rates of NO synthesis. Increased systemic synthesis
of NO in the systemic form of NTN is supported by our finding of
lower plasma arginine levels in these rats compared with normals
and our previous observation of increased urinary NO2 excre-
tion. The potentiating effects of nephrotoxic globulin might be
due to some anti-endothelial activity, as some nephrotoxic glob-
ulins have specificity against tissues other than the glomerulus
[24]. It could also be due to endotoxin in the preparation [25].
However, our normal rabbit globulin that was prepared by the
same precipitation methods did not produce a hypertension, so
this latter explanation is unlikely.
Our results do not support a cytotoxic role for NO, at least in
the early phase of this model, despite considerable evidence that
NO is an important mediator of macrophage cytotoxicity [26], and
evidence for a pro-inflammatory role in immune complex-medi-
ated lung injury [27]. Plasma arginine depletion exacerbated
glomerular injury in the early phase of NTN, suggesting a
protective role for NO. Possible mechanisms of the protective
effects are through counteracting vasoconstriction, inhibiting
thrombosis or scavenging oxygen radicals. The relative impor-
tance of these different mechanisms may depend on the severity of
glomerular injury. The use of arginase appears an effective
strategy for the study of acute inhibition of NO synthesis. The
effect of longer term arginase administration on glomerulonephri-
Fig. 6. A. Glomerular hypercellularity four days after unilateral NTN. There tis remain to be determined.
was no significant difference with and without arginase. B. Normal
glomerulus for comparison (H+E stain, X280 magnification). Acknowledgments
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